Chronic subdural hematoma (CSDH) is seen frequently in daily neurosurgical practice. Its incidence is about five per 100.000 per year in the general population but it is higher among those aged 70 years and older \[[@ref1]\]. Trauma is the most important risk factor for the development of CSDH \[[@ref2], [@ref3]\].

The clinical picture of CSDH varies widely. Common symptoms in the largest series with medical reports on 2300 patients were simple treatment-refractory headache and sensorimotor and neuropsychiatric changes such as amnestic or concentration deficits \[[@ref2]\]. Surgical treatment of CSDH in symptomatic patients is still the "gold standard " therapy. The following types of surgical treatment approaches have been used: craniotomy, twist-drill craniostomy, burr-hole drainage with placement of a subdural drain or subgaleal drainage system, percutaneus subdural tapping and endoscopy with variable results.

In this article, we described, and compared the consequences of subdural and subgaleal closed drainage systems.

MATERIALS AND METHODS {#sec1-2}
=====================

From January 2009 to December 2011, we operated on 78 adult patients with chronic subdural hematomas in the department of Neurosurgery of Erciyes University Faculty of Medicine. All of the patients were treated surgically and analyzed retrospectively. Our patients were classified into two groups according to the operative procedure as follows: Group I, one or two burr-hole craniostomy with subgaleal closed system drainage, and Group II, one or two burr-hole craniostomies with subdural closed drainage system. The choice of the surgical technique was decided randomly by different surgeons. Preoperative clinical laboratory parametres measured included bleeding time, platelet count, prothrombin time, and activated partial thromboplastin time. Our study was approved by institutional ethics committee. In all cases, computed tomography and/or magnetic resonance ımages was used for diagnosis and postoperative evaluation. We measured thickness of the hematoma using a PACS (Infinitt. Co. Ltd. Seoul, Korea) viewer. Two groups had similar preoperative clinical data.

Standard supplemental statistical methods (mean, standard deviation and percentage) were used to evaluate the results of this study. The normality of the range of the parametric variables was evaluated with the Kolmogrov-Smirnov test. Result were analyzed using Student t-test, Mann-Whitney U and Wilcoxon Test. P-value of \<0.05 was considered to be statistically significant.

Surgical techniques {#sec2-1}
-------------------

All operations were performed under sedo-analgesia and general anesthesia. Patients were placed in the supine position with the head elevated and inclined 20--40 degrees towards the contralateral side of the hematoma. As a prophylactic antibiotic, 1 g cefazolin injection was given before the skin incision.

A skin incision of approximately 4 to 5 cm in length was made over the maximum thickness of the hematoma, generally the parietal bump. Burr-hole craniostomy was performed with the high speed pneumatic drills. The dura mater was incised and bleeding foci were coagulated by bipolar coagulation. The outer and inner membranes of the hematoma were coagulated and incised and hematoma was drained. Then irrigation of the hematoma cavity with sterile saline at 37°C was made until clear fluid came out of the burr hole. A 10 F drainage tube was placed in the subgaleal area and the terminal end of the tube was positioned over the burr hole in Group I ([Figure 1](#F1){ref-type="fig"}). In Group II, the drainage tube was inserted and left in the subdural space. After we closed the incision, the tube was connected to a closed drainage system. The drainage tubes were removed 48--72 hours after the surgery in Groups I and II. Prophylactic antibiotics were used so long as the drainage continued.

![Schematic illustration: subgaleal drainage system and single burr-hole craniotomy.](NCI-2-115-g001){#F1}

RESULTS {#sec1-3}
=======

Distribution of males and females in each group was 28:8 in Group I, 29:9 in Group II. The mean ages of the patients in Groups I, and II were 68.1±14.4 and 66.1±13.7 years, respectively. Clinical features of the patients are listed in [Table 3](#T1 T2 T3){ref-type="table"}. Neurologic performances of the patients were evaluated based on Markwalder Grading Scale (MGS) ([Table 1](#T1){ref-type="table"}).

###### 

Markwelder Grade Scale

  -----------------------------------------------------------------------------------------------------------------------------
  0 Patient neurologically normal
  1 Patient alert and oriented, mild symptoms such as headache, absent or mild neurological deficits such as reflex asymmetry
  2 Patient drowsy or disoriented with variable neurological deficits such as hemiparesis
  3 Patient stuporous but responding appropriately to noxious stimuli, severe focal signs such as hemiplegia
  4 Patient comatose with absent motor responses to painful stimuli, decerebrate or decorticate posturing
  -----------------------------------------------------------------------------------------------------------------------------

###### 

Etiology

                               Group I   Group II
  ---------------------------- --------- ----------
  Recent head injury           28        30
  Shunt related                2         2
  Use of anticoagulant drugs   4         5
  Unknown                      2         1

###### 

Clinical features

                             Group I         Group II
  -------------------------- --------------- ----------------
  Sex                                        
   Male                      28              29
   Female                    8               9
  Median age                 68.1 (47--86)   66.1 (24--109)
  Presenting symptoms                        
   Headache                  18              20
   Decreased consciousness   7               9
   Limb weakness             15              13
   Seizure                   1               3
   Diplopia                  --              1
   Cognitive dysfunction     5               3
   Vertigo                   4               5
   Unilateral                34              35
  Bilateral                  2               3

Fifty-eight (78.3%) patients had a history of head trauma and nine patients (11.5%) were receiving anticoagulant therapy. Four patients had had a ventriculoperitoneal shunt inserted previously for hydrocephalus. No precipitating factors could be identified in three patients ([Table 2](#T2){ref-type="table"}).

Headache was the most common symptom of the patients (51.3%). The other symptoms and signs were limb weakness (51.3%), decreased consciousness (20.5%), seizure (5.1%), diplopia (1.2%), vertigo (11.5%), and cognitive dysfunction (10.2%). Hematoma was bilateral in 5 patients (6.4%) ([Table 3](#T3){ref-type="table"}). There was no significant difference between groups as for clinical presentations. No statistically significant differences were found regarding the distribution of genders and age groups between groups.

In Group I, 6, and in Group II, 5 patients had grade 3 neurologic performance status based on Markwalder Grading System. At the time of discharge, in Group I, 4, and in Group II, 2 patients had grade 3 neurologic performance status based on Markwalder Grading System. The mean thickness of the hematoma was 2.32 cm preoperatively in Group I and 2.38 cm in Group II. Any statistically significant intergroup differences were not found as for the thickness of hematomas (p\>0.05) ([Table 4](#T4){ref-type="table"}).

###### 

Comparison of demographic and related factors

  Factors                  Group I   Group II   p
  ------------------------ --------- ---------- ------
  Mean age                 68.1      66.1       0.18
  Markwelder's Score       1.66      1.69       0.24
  Recurrences, n (%)       2 (5.5)   3 (7.8)    0.04
  Width of hematoma (cm)   2.32      2.38       0.46
  Pneumocephalus (%)       38.8      47.3       0.02

All the patients were checked with CT or MRI at the 2., 8., and 12. postoperative weeks. All the patients were discharged between the 2.--5. postoperative days. We followed up the patients for 3 months. The patients have been followed clinically and in the third month control CT, the complete resorption of the hematomas was observed (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

![Group I and subgaleal drainage system. 72 M / headache, decreased consciousness and hemiparesis **(A)** Preoperative CT imaging **(B)** Postoperative second week **(C)** Postoperative eighth week.](NCI-2-115-g002){#F2}

![Group II and subdural drainage system. 40 M / headache and vertigo **(A)** Preoperative MRI **(B)** Postoperative second week **(C)** Postoperative eighth week.](NCI-2-115-g003){#F3}

Symptomatic pneumocephalus did not develop in patients. Postoperative complications and outcomes of the patients with CSDH are shown in [Table 5](#T5){ref-type="table"}.

###### 

Complications and outcomes in Groups I and II

                   Group I   Group II
  ---------------- --------- ----------
  Pneumocephalus   14        18
  Seizures         1         2
  Infection        --        1
  Recurrence       2         3

A subdural empyema occurred in a patient from Group II who was treated with antibiotics and surgery. Seizures were treated with anticonvulsant drugs (phenytoin or sodium valproate). Recurrence of CSDH was diagnosed according to clinical (aggravation of headeache, change in conciousness, and worsening of preexisting neurological deficit) and/or radiological criteria (CT scans). Four patients were reoperated for recurrences between 12--20 days after the operation with the same methods. But one patient was reoperated with craniotomy in Group II with the indication of acute subdural hematoma. In the majority of the patients, neurologic status improved after the operation.

DISCUSSION {#sec1-4}
==========

Chronic subdural hematoma is seen in geriatric patients, and trauma is the most important reason for CSDH \[[@ref1], [@ref2], [@ref3]\]. Treatment options for CSDH are surgical or nonsurgical therapies. Non-operative treatment of CSDH consists of the use of steroids (low dose dexamethasone) or mannitol \[[@ref4], [@ref5], [@ref6], [@ref7]\]. Operative treatment of CSDH in symptomatic patients is yet the gold standard of therapy because it allows urgent decompression of the subdural space \[[@ref8]\].

Different operative treatment options have been reported for CSDH, such as twist-drill craniotomy, small craniotomy and endoscopic removal, large craniotomy and membranectomy or burr-hole craniostomy with or without continuous closed drainage system and continuous subgaleal suction drainage or burr-hole trepanation and a subperiostal drainage system \[[@ref9], [@ref10], [@ref11], [@ref12], [@ref13], [@ref14], [@ref15]\].

In this study, we compared two surgical techniques including burr-hole craniostomy, subdural and subgaleal drainage systems. Besides, we discussed the advantages and disadvantages of these techniques.

According to Gazzeri et al. subgaleal closed drainage system has a low rate of recurrence and pneumocephalus \[[@ref14]\]. Also, some researchers have reported lower recurrence rates with the use of postoperative drains \[[@ref16]\]. In addition, clinical data support the beneficial effects of intraoperative irrigation in order to resolve hematoma and reduce recurrences. Furthermore, use of closed system drainage reduces the risk of recurrence without additional risk of complications \[[@ref17]\]. In our study, rate of recurrence was 5.5% in Group I, and 7.8% in Group II.

Additionally, rates of pneumocephalus were 43.75% in Group I and 47.3% in Group II. Consequently, these techniques have a lower recurrence rate and pneumocephalus.

The craniotomy technique has a low recurrence rate. But it is more invasive and has a greater morbidity and mortality \[[@ref2], [@ref18]\]. Nevertheless, craniotomy as a management of CSDH has indications as solid hematoma and multiple recurrences \[[@ref1]\]. In our study, we used craniotomy for reoperation of one patient who developed a solid hematoma.

Its other surgical complication is postoperative seizures \[[@ref19]\]. In our experience, rate of seizures was 2.7--5.2% in Groups I and II. Seizure rates of 2--19% have been reported in CSDH patients \[[@ref20], [@ref21]\].

The other common complication is symptomatic pneumocephalus. This complication has been reported to range from 0 to 10% in the literature \[[@ref14], [@ref20], [@ref22]\]. In the present study this complication did not develop in any patient in Groups I and II. Similarly, Gazzeri et al. did not report any incident of symptomatic pneumocephalus in their series \[[@ref14]\].

Subdural empyema occurred in one of the patient who had undergone subdural drainage. The incidence of postoperative empyema has been reported to range between 0, and 6 percent \[[@ref23], [@ref24], [@ref25], [@ref26]\]. Similarly, Gazzeri et al. and Zumofen et al. reported a very low rate of subdural empyema in association with extracranial placement of the drain \[[@ref14], [@ref15]\]. In addition, Zumofen et al. advocated that the placement of extracranial drainage can reduce the incidence of deep brain infection which might develop as a consequence of surgical treatment of CSDH \[[@ref15]\].

Postoperative acute hemorrhage was reported in some series in association with the use of subdural drain and burr-hole techniques \[[@ref27]\]. Gazzeri et al. \[[@ref14]\] and Zumofen et al. \[[@ref15]\] have signified that the use of a subdural drain with burr-hole may lead to intracerebral hemorrhage. These drainage catheters may penetrate into the brain parenchyma or injure bridging veins \[[@ref5], [@ref28]\]. Placement of subgaleal drainage tube has not any risk of these complications. In our series, we haven't seen any postoperative acute hemorrhage.

Conclusions {#sec2-2}
-----------

Subdural and subgaleal drainage system have a higher cure rate and a lower risk of recurrence. However, subgaleal drainage system is relatively less invasive, safe, and technically easy. Regarding safety, we didn't see any subdural empyeme in our patients for whom we used subgaleal drainage system. Since the drainage tube is not in direct contact with the brain tissue and membranes of CSDH in this method, theoretically, there is no risk of acute cerebral hemorrhage. So subgaleal drainage system is practically applicable for higher risk patients.
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